| Product NDC: | 16590-137 |
| Proprietary Name: | KETOPROFEN |
| Non Proprietary Name: | KETOPROFEN |
| Active Ingredient(s): | 75 mg/1 & nbsp; KETOPROFEN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-137 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073517 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110118 |
| Package NDC: | 16590-137-62 |
| Package Description: | 84 CAPSULE in 1 BOTTLE (16590-137-62) |
| NDC Code | 16590-137-62 |
| Proprietary Name | KETOPROFEN |
| Package Description | 84 CAPSULE in 1 BOTTLE (16590-137-62) |
| Product NDC | 16590-137 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | KETOPROFEN |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110118 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | KETOPROFEN |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |